AU Patent

AU2019248350B2 — Process for making sarecycline hydrochloride

Assigned to Almirall LLC · Expires 2023-07-27 · 3y expired

What this patent protects

The described invention relates to sarecycline, related compounds, intermediates and salts thereof and processes for preparing the same.

USPTO Abstract

The described invention relates to sarecycline, related compounds, intermediates and salts thereof and processes for preparing the same.

Drugs covered by this patent

Patent Metadata

Patent number
AU2019248350B2
Jurisdiction
AU
Classification
—
Expires
2023-07-27
Drug substance claim
No
Drug product claim
No
Assignee
Almirall LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.